1. Home
  2. CTNT vs CVKD Comparison

CTNT vs CVKD Comparison

Compare CTNT & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheetah Net Supply Chain Service Inc.

CTNT

Cheetah Net Supply Chain Service Inc.

HOLD

Current Price

$0.24

Market Cap

4.0M

Sector

N/A

ML Signal

HOLD

Logo Cadrenal Therapeutics Inc.

CVKD

Cadrenal Therapeutics Inc.

HOLD

Current Price

$1.08

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTNT
CVKD
Founded
2016
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
3.9M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
CTNT
CVKD
Price
$0.24
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
745.2K
1.2M
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
57.74
23.94
EPS
N/A
N/A
Revenue
$1,288,536.00
N/A
Revenue This Year
$42.49
N/A
Revenue Next Year
$22.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
182.69
N/A
52 Week Low
$0.02
$1.00
52 Week High
$4.21
$14.64

Technical Indicators

Market Signals
Indicator
CTNT
CVKD
Relative Strength Index (RSI) 17.69 22.65
Support Level $0.02 N/A
Resistance Level $1.55 $2.23
Average True Range (ATR) 0.12 0.17
MACD -0.05 -0.01
Stochastic Oscillator 0.00 5.43

Price Performance

Historical Comparison
CTNT
CVKD

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to treat heparin-induced thrombocytopenia (HIT), a deadly immune-mediated thrombotic disorder. The pipeline includes two additional clinical-stage assets: tecarfarin and frunexian. Tecarfarin is an oral vitamin K antagonist (VKA) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation. Frunexian is a first-in-class, Phase 2-ready intravenous Factor XIa inhibitor designed for acute care settings where contact activation of coagulation by medical devices or artificial surfaces.

Share on Social Networks: